Bertelsmann Stiftung: A majority of Europeans believe in a Ukraine victory
16.2.2023 08:00:00 CET | news aktuell GmbH | Press Release
One year into the war in Ukraine, 61% of Europeans believe that the country will prevail. Germans, however, are not quite so optimistic, although a 55% majority believes in a Ukrainian victory. These are the findings of the EU-wide survey conducted by eupinions. It is published in cooperation with the Belgian King Baudouin Foundation.
Europeans are not only betting on victory, 68% also see the war of aggression as a matter affecting them all, because it is an attack on the whole of Europe. Most EU citizens polled also see Ukraine in a battle to defend a set of common values that are shared by all European states.
“This unity is an important signal,” says Isabell Hoffmann, Europe expert at the Bertelsmann Stiftung and head of eupinions. “Common values are a cornerstone of the support provided to Ukraine by the EU and its member states. The longer this war drags on, the more important it is for Ukrainians to know that the majority of EU citizens acknowledge their achievements.”
A total of 62% of Europeans agree with the statement that Ukrainians are also fighting for Europe’s freedom and prosperity.
The greatest differences are revealed in the question of the effectiveness of sanctions against Russia. While 40% of respondents consider sanctions to be an effective instrument, the same number consider them ineffective, and around 20% are undecided.
There is, however, a consensus on the question of who is to blame for the war: Here, too, 66% say that Russia bears responsibility for the war.
Also 66% express a sense of unease, stating that the world today is a dangerous place and that it used to be a much better place.
“The level of anxiety is exceptionally high right now. Given the brutality of the war, the toll it’s taking, and the overall level of threat, this is not surprising. What’s really remarkable, however, is that the most anxious are just as supportive of Ukraine as are EU citizens as a whole,” explains Hoffmann.
For more information, please visit: www.eupinions.eu
About the Bertelsmann Stiftung: Inspiring people. Shaping the future.
The Bertelsmann Stiftung is committed to enabling social participation for everyone – politically, economically and culturally. Our programs include Education and the Next Generation, Democracy and Social Cohesion, Digitalization and the Common Good, Europe’s Future, Health, and Sustainable Social Market Economies. In our work, we focus on people, since only they can change the world and make it better. We share knowledge, promote expertise and develop solutions. A nonprofit foundation, the Bertelsmann Stiftung was established in 1977 by Reinhard Mohn. For more information, please visit: www.bertelsmann-stiftung.de
For questions please contact our expert:
Isabell Hoffmann, head of eupinions and co-author
Phone: +49 30 27 57 88 126
About news aktuell GmbH
As wholly owned subsidiary of dpa, news aktuell provides business and organizations with effective access to media and consumers. Via the smart tools ots and zimpel, PR content accesses all media formats, including classical print, high click-rate online portals and social networks. In addition, news aktuell publishes all its customers’ PR content on www.presseportal.de, one of the PR portals with the greatest reach in Germany. By this means, all the relevant multipliers are reached globally, from editors, via digital influencers right up to specialist bloggers and interested consumers. news aktuell has been on the market since 1989. The company, with a staff complement of more than 135, has its headquarters in Hamburg. Other offices are in Berlin, Dusseldorf, Frankfurt und Munich.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Grünenthal partners with DKSH to bring four important pain medicines to eight new markets in Asia-Pacific28.9.2026 09:07:45 CEST | Press Release
The partnership will bring Qutenza®, Vimovo®, Palexia® and Zomig® to people living with pain in Asia-Pacific, spanning Hong Kong, Indonesia, Malaysia, Philippines, Singapore, Taiwan, Thailand and Vietnam. Pain is a significant healthcare challenge in the region, due to the ageing population and the high burden of chronic diseases.[i],[123], The partnership is a key step in Grünenthal’s strategy to enhance patient care and expand access to its innovative medicines.
Strong international interest in Security Essen and EUDEX23.9.2026 16:32:27 CEST | Press Release
From Albania to Uzbekistan – visitors from almost 90 nations Trade visitors from 89 nations to date, international delegations and companies from more than 40 countries: Security Essen and the new Euro Defence Expo (EUDEX) are bringing guests from numerous parts of the world to Messe Essen this week. Visitors from the Netherlands, Belgium, Switzerland, the UK, Poland, the Czech Republic and France are particularly well represented. But experts are also travelling from more distant countries such as Argentina, Ukraine, Singapore and South Korea to network across borders and find out about the latest security and defence technologies. Security Essen focuses on civil security, whilst the inaugural EUDEX is dedicated to the defence industry.
Major update for Thermomix® and Cookidoo®– ecosystem gets smarter, more personalised and more global21.9.2026 13:26:40 CEST | Press Release
Thermomix® takes its ecosystem to the next level: With the new Cookidoo® Assistant and Recipe Translation benefits, the largest culinary community gains comprehensive AI features. In addition, Arabic is introduced as a new language option on Thermomix® TM7, following a long-standing community demand.
Grünenthal acquires cancer treatment Stivarga®21.9.2026 10:53:31 CEST | Press Release
Latest step in Grünenthal’s strategy to acquire established medicines that serve clear medical needs, leverage its commercial and operational capabilities, and drive growth. Stivarga® (regorafenib) is an established oral treatment for certain advanced cancers, including metastatic colorectal cancer, gastrointestinal stromal tumours (GIST) and hepatocellular carcinoma (liver cancer). It is approved and available in more than 90 markets worldwide. Grünenthal has invested around €2.6 billion in successful M&A transactions since 2017, significantly strengthening its profitability and further funding its innovative research pipeline.
S&Ds to von der Leyen: Europe must deliver for people and strengthen its sovereignty16.9.2026 07:36:46 CEST | Press Release
STRASBOURG, 15 September 2026 Ahead of Commission President Ursula von der Leyen’s State of the Union address and debate in Strasbourg on September 16, 2026, the Socialists and Democrats in the European Parliament (S&D) call for a change of direction: away from deregulation and towards better living and working conditions for Europeans, tangible social justice, and a stronger, more sovereign Europe. Iratxe García Pérez, president of the S&D Group in the European Parliament, said: “Europe is facing a choice. Not simply between different policies or political parties, but between two very different visions of our future. One vision is built on fear, power without limits, nationalism and the rule of the strongest. The other vision is the Europe we believe in: a Europe that protects its people, defends democracy and international law, fights climate change, guarantees social rights and has the strength to decide its own future.”* A Europe that delivers for its people The S&D Group has deli
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
